These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10591068)

  • 1. Is bradykinin a mediator of renal neuropeptide Y effects?
    Bischoff A; Neumann A; Dendorfer A; Michel MC
    Pflugers Arch; 1999 Nov; 438(6):797-803. PubMed ID: 10591068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis.
    Bischoff A; Rascher W; Michel MC
    Am J Physiol; 1998 Oct; 275(4):F502-9. PubMed ID: 9755121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
    Bischoff A; Erdbrügger W; Smits J; Michel MC
    J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.
    Czyborra C; Bischoff A; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):37-44. PubMed ID: 16521006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
    Bischoff A; Michel MC
    Can J Physiol Pharmacol; 2000 Feb; 78(2):93-9. PubMed ID: 10737671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats.
    Bischoff A; Limmroth V; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):704-8. PubMed ID: 9694924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
    Nasjletti A; Colina-Chourio J; McGiff JC
    Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal Mas and AT
    O'Neill J; Healy V; Johns EJ
    Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of neuropeptide Y.
    Bischoff A; Michel MC
    Pflugers Arch; 1998 Mar; 435(4):443-53. PubMed ID: 9446690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat.
    Bagaté K; Grima M; De Jong W; Imbs JL; Barthelmebs M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):281-7. PubMed ID: 11284442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that intrarenal bradykinin plays a role in regulation of renal function.
    Siragy HM
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E648-54. PubMed ID: 8238340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM; Jaffa AA; Margolius HS
    Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of kinins in the control of renal papillary blood flow, pressure natriuresis, and arterial pressure.
    Tornel J; Madrid MI; García-Salom M; Wirth KJ; Fenoy FJ
    Circ Res; 2000 Mar; 86(5):589-95. PubMed ID: 10720421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of renal prostaglandins to the natriuretic action of bradykinin in the dog.
    Blasingham MC; Nasjletti A
    Am J Physiol; 1979 Sep; 237(3):F182-7. PubMed ID: 474758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype.
    Bischoff A; Michel MC
    Endocrinology; 1998 Jun; 139(6):3018-21. PubMed ID: 9607814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of central and peripheral neuropeptide Y on sodium and water excretion in the rat.
    Smyth DD; Wilson JR; Seidlitz E; Thom SL
    Physiol Behav; 1989 Jul; 46(1):9-11. PubMed ID: 2813560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adenosine on water and sodium excretion.
    Yagil Y
    J Pharmacol Exp Ther; 1994 Feb; 268(2):826-35. PubMed ID: 8113995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.